• Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News – India
    • BioMedical
    • BioBusiness
    • BioResearch
    • BioGadgets
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues
    • Biotech Express Issues – Access Page
  • Subscribe
  • Board
  • Advertise
Facebook Twitter Instagram
Trending
  • Editorial: What serious side effects reported after inoculation of Indian COVID-19 vaccines: Survey of AEFI reports
  • COVID-19 scientists are facing an avalanche of abuse, Science survey shows
  • Editorial: Plastic found in human blood – Call an urgency to switch to bioplastic
  • Guestorial: Demand for Nationalization of Healthcare Services in India
  • 19 Year Old Allegedly Dies Post Covishield Vaccination: Kerala High Court Seeks Centre’s Response On Parents’ Plea
  • Phablecare Raises ₹187 Cr In Funding
  • Pfizer Hired 1,800 Additional Employees In 2021 To Process Huge Increase In Vaccine Adverse Events
  • Experts write to PM against WTO proposal on COVID-19 vaccine waivers
Biotech Express Magazine
  • Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News – India
    • BioMedical
    • BioBusiness
    • BioResearch
    • BioGadgets
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    January 16, 20211

    Interview – Prof Rajeev K Varshney “The Youngest Indian Scientist (47)” who achieved an h-index of 100 recently

    Recent
    March 30, 2022

    Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey

    January 24, 2022

    Interview: Prof Kailash Chander Bansal, Secretary, National Academy of Agricultural Sciences (NAAS), India

    January 23, 2022

    Interview – Dr Heera Lal: How an IAS officer using Biotech approaches to transform Indian villages into “Organic Villages”

  • Issues
    • Biotech Express Issues – Access Page
  • Subscribe
  • Board
  • Advertise
Biotech Express Magazine
You are at:Home»Articles»Drs Ella deserve Padma Award for their innovations and management in biotechnology: India’s pioneer recombinant biologist Prof Ramareddy Guntaka

Drs Ella deserve Padma Award for their innovations and management in biotechnology: India’s pioneer recombinant biologist Prof Ramareddy Guntaka

0
By Biotech Express on February 26, 2022 Articles, Articles- Editorials, Biotech News - India

Drs. Krishna Ella and Suchitra Ella traveled through a rough road to bring Bharat Biotech to the forefront in vaccine production. Dr. Poonawala also made Serum Institute the major Vaccine Production unit in the world. I am happy to see that the Government of India honored them with Padma awards.

Ramareddy

As I recall one of his interview, he said the Indian biotech sector is today worth about USD 7 billion and according to the National Biotechnology Development Strategy, the target is to make it into a USD 100 billion industry by 2025, which he surely can support through his various initiatives as his company is doing great, said Prof Guntaka Ramareddy.

This year Dr Krishna Ella, Chairman, Hyderabad based Bharat Biotech along with Suchitra Ella, Director of the company and Dr Cyrus Poonawalla, founder of Pune-based Serum Institute of India (SII) are all set to be bestowed with Padma Awards. Both pharmaceutical firms – SII and Bharat Biotech – have led the country towards becoming self-sufficient in Covid-19 and other vaccines production and making them available at the lowest possible price in the world.

Dr Ella has joined an elite club of Padma awardee scientists like Varaprasad Reddy, Kiran Mazumdar Shaw who were not only the scientists but biopreneurs who started from scratch and touched skyline though their efforts, dedication and scientific temper.

I also remember how quickly he made Hepatitis-B vaccine immediately after us when I developed India’s first recombinant product and first Hepatitis b vaccine of India for Varaprasad Reddy (Padma Bhushan- 2005) who also did great work to start Shantha biotech in 1993 and with this product in hand becomes the first Indian company to develop, manufacture and market recombinant human healthcare products in India. In 1997, Shantha developed and commercialised India’s first r-DNA Hepatitis-B vaccine.

Adverse Events which are nearly absent in Covaxin as compared to other vaccines is a great advantage of scientific temper. Since he chose the dosage very low, it has very less chance of any adverse reaction unless a live virus enters the vial. On the other hand, it is proved after many reports that Moderna, Pfizer, Astrazeneca or SII’s, etc. vaccine have serious side effects as compared to covaxin. On this note Dr Ella deserves padma awards for his most safe and effective vaccine in times when an innovative and entrepreneurship approaches both were required.

It is also believed by some that committees does sometime makes mistakes while deciding awards, it is imperative to note that Dr Ella was mistakenly placed in Trade category though he was the chief scientist behind the vaccine development and thus would have come under Science or medicine category. There is a huge difference between the selection criteria of each of PADMA AWARDEE and there could be change in category, I believe the decision has come nice when the Indian govt. has recognized efforts of Dr Krishna Ella toward his scientific contribution in novel vaccine development.

About Suchitra Ella

Mrs. Suchitra Ella is the Joint Managing Director of Bharat Biotech, which she co-founded with his husband Dr. Krishna Ella in 1996. With experience in customer operations, finance, marketing and business development, Mrs. Ella is a strong pillar of support and guidance at Bharat Biotech, overseeing a wide range of operations in the company.

Mrs. Ella holds a BA in Economics and Social Sciences from the University of Madras. She followed this up with diploma in business development from UWCU—Madison, diploma in real estate management from University of South Carolina and post-graduate diploma in patent law from NALSAR—Hyderabad. Several awards have been conferred on her including the South Indian Business Achievers Award 2016, Zee TV Best Women Entrepreneur Award, SAARC Women Entrepreneur Award etc.

Mrs. Suchitra Ella is also the Chairperson of CII Indian Women Network. She serves on the Boards of ISB Well Wisher’s Trust and United Way Hyderabad—an International Charity Partner focused on social empowerment in local communities with focus on livelihoods, health and education. She was a former Board member of TTD. Mrs. Suchitra strongly believes in corporate citizenship and social responsibility. She spearheads the CSR initiatives of the company.

About Prof Ramareddy V Guntaka

Professor Guntaka is Emeritus Professor in Department of Microbiology, Immunology & Biochemistry, University of Tennessee, Health Sciences Center, Memphis, TN, USA and Chairman and Chief Scientist at Sudarshan Biotech Pvt Ltd., India.

• Prof Guntaka was one of the four members team that discovered Proto-oncogenes, genes implicated in causing cancer.
• Prof Guntaka was the first one to molecularly clone the entire genome of Rous Sarcoma Virus
• Prof Guntaka was the key scientist behind the successful development of the Recombinant Hepatitis B Vaccine.by Shantha Biotech
• Prof Guntaka was also the key scientist behind the successful development of interferon alpha used to treat hepatitis B infections.
• Prof Guntaka was also the first scientist to clone and study the complete genome of the Indian strains of Hepatitis C virus.

 

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

Editorial: What serious side effects reported after inoculation of Indian COVID-19 vaccines: Survey of AEFI reports

Editorial: Plastic found in human blood – Call an urgency to switch to bioplastic

Guestorial: Demand for Nationalization of Healthcare Services in India

Leave A Reply Cancel Reply

Current Issue – April 2022

                   VIEW SUBSCRIPTION PLANS

JOBS/NOTIFICATIONS

   

         CLICK HERE FOR RECENT NOTICES

Recent Posts
  • Editorial: What serious side effects reported after inoculation of Indian COVID-19 vaccines: Survey of AEFI reports April 25, 2022
  • COVID-19 scientists are facing an avalanche of abuse, Science survey shows April 24, 2022
  • Editorial: Plastic found in human blood – Call an urgency to switch to bioplastic April 24, 2022
  • Guestorial: Demand for Nationalization of Healthcare Services in India April 24, 2022
  • 19 Year Old Allegedly Dies Post Covishield Vaccination: Kerala High Court Seeks Centre’s Response On Parents’ Plea April 15, 2022
  • Phablecare Raises ₹187 Cr In Funding April 11, 2022
  • Pfizer Hired 1,800 Additional Employees In 2021 To Process Huge Increase In Vaccine Adverse Events April 9, 2022
  • Experts write to PM against WTO proposal on COVID-19 vaccine waivers April 8, 2022
  • Bose Institute Scientists earn retraction due to manipulation April 5, 2022
  • WHO suspends Covaxin supply to UN agencies April 4, 2022
  • Lockdowns, Not the Pandemic, Created Havoc April 1, 2022
  • WHO selects Biological E to transfer mRNA COVID vaccine tech April 1, 2022
  • Dr. Reddy’s Laboratories and MediCane Health Announce the Launch of Medical Cannabis Products in Germany April 1, 2022
  • New Zealand High Court ENDS Vaccine Mandate: “It’s a Gross Violation of Human Rights” April 1, 2022
  • S&T Ministry to support startup in medical implants March 31, 2022
  • FDA Clears Marketing of Genome-Edited Beef Cattle March 30, 2022
  • Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey March 30, 2022
  • Undisclosed industry payments rampant in drug-trial papers in Australia March 29, 2022
  • Fraud Trial of Former Theranos Executive Ramesh’ Sunny’ Balwani Begins March 29, 2022
  • Substandard, fake medical products increased by almost 47% from 2020 to 2021 during pandemic: report March 29, 2022
  • Editorial: Biofuels in India – a perfect waste to wealth and net zero emission energy option March 29, 2022
  • Bharat Biotech and BIOFABRI partner to develop, manufacture and distribute novel TB vaccine March 28, 2022
  • Fibroheal raises debt funding from BIRAC March 28, 2022
  • Editorial – Energy, Renewable Energy and Bioenergy March 28, 2022
  • IISc, India to set up public health centre with Rs105 cr funding from philanthropist March 27, 2022
  • Tamil Nadu makes scientifically dubious claim on vaccines in the Supreme Court March 27, 2022
  • Guest Article: GENE EDITED-CRISPERED FLOWERS: Blooming with grace March 27, 2022
  • Dr. Anthony Fauci, Biden admin operated with missing data as CDC issued pandemic guidance, emails show March 25, 2022
  • Contents – February 2022 March 3, 2022
  • Drs Ella deserve Padma Award for their innovations and management in biotechnology: India’s pioneer recombinant biologist Prof Ramareddy Guntaka February 26, 2022
Archives
Categories
  • Articles
  • Articles- Editorials
  • Articles- Guestorials
  • Articles- News Reports
  • BioControversial
  • BioEvents
  • BioGadgets
  • BioPolicies
  • BioResearch – Academic
  • BioResearch – Industry
  • Biotech – Agriculture
  • Biotech – Healthcare
  • Biotech – Supplies
  • Biotech News – Featured
  • Biotech News – India
  • Biotech News – Industry
  • Contents
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • SARS- CoV2 & COVID-19 Updates
  • startups
About Us

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports,  Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Call us: _91-9311986177

Email – biotechexpressindia@gmail.com

About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Policy and Guidelines

Submission policies

Peer review policy    

Copyright policy

 

Follow Us
  • Facebook
  • Twitter
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2020 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.